Birmingham e-cigarette expo faces falling attendance and enthusiasm

Oct.26.2024
Birmingham e-cigarette expo faces falling attendance and enthusiasm
On the first day of the expo, the atmosphere was subdued and the crowds sparse. Many exhibitors expressed disappointment at the low turnout, commenting that "vape expos seem to decline year on year". Some exhibitors attributed this to the current stability of the UK vaping market, which lacks the early stage uncertainty and demand for rapid expansion of previous years.

The e-cigarette exhibition in Birmingham, UK opened as scheduled at Birmingham National Exhibition Center on October 25th. On the first day of the exhibition, there were few attendees and the atmosphere was quite low-key. Many exhibitors admitted that they were disappointed by the lackluster turnout, with some expressing the sentiment that "e-cigarette exhibitions are getting worse year after year.

 

Birmingham e-cigarette expo faces falling attendance and enthusiasm
Exhibition site | Image source: 2Firsts

 

 

Exhibitors admit: Birmingham trade show is declining year by year.

 

 

Birmingham e-cigarette expo faces falling attendance and enthusiasm
Exhibition scene | Image source: 2Firsts

 

According to exhibitors who have participated in several trade shows, in the past few years there was relatively large attendance, with many emerging brands using it as a platform to showcase their latest products and technologies to the UK and even Europe. However, this year's trade show had sparse attendance, in stark contrast to previous years. Many exhibitors seemed bored at their booths, and the atmosphere at the trade show was mainly filled with familiar faces, with the enthusiasm of the staff somewhat diminished.

 

Birmingham e-cigarette expo faces falling attendance and enthusiasm
Exhibition scene | Image source: 2Firsts

 

An unnamed exhibitor stated, "The enthusiasm at the trade show is not as high as before, and there are hardly any visitors walking around the exhibition area.

 

Birmingham e-cigarette expo faces falling attendance and enthusiasm
Exhibition Scene | Image source: 2Firsts

 

On the first day of the exhibition, 2Firsts observed that there were few visitors stopping in the aisles between booths, and the displays and interactive activities of exhibitors did not attract many participants. The atmosphere at the exhibition was far from the lively scene that most exhibitors had hoped for.

 

Many exhibitors expressed their feelings of disappointment during interviews, stating that this year's exhibition has been sluggish. Some exhibitors believe that exhibitions like the Birmingham e-cigarette show are declining year by year. A brand representative with years of experience pointed out that the attractiveness of the Birmingham exhibition is not as strong as it used to be.

 

The Birmingham exhibition this year is really not as good as previous years. There are noticeably fewer exhibitors and visitors compared to before," the individual said.

 

 

Decline in enthusiasm for participation in exhibitions due to stable market conditions.

 

 

Behind the cooling of the exhibition, there are deep-rooted reasons in the industry structure and market demand of the e-cigarette market in the UK. According to one exhibitor's analysis, the UK e-cigarette market has now stabilized and no longer has the market uncertainty and demand for emerging expansion as it did in the early days.

 

In earlier years, information was not as transparent as it is now. Agents and distributors from various regions needed to attend trade shows to access new products and distribution opportunities. However, now that channels have become more stable, agents are not as reliant on trade shows as they used to be, leading to a decline in enthusiasm for participation. He explained that in the past, trade shows served as a bridge for brands and distributors to connect, but as market channels have gradually stabilized, the demand for participation from many distributors and agents has significantly decreased.

 

In addition, the cooling trend of the exhibition is not only occurring in the UK market. The exhibitor also revealed that when they participated in a trade show organized by the Russian e-cigarette association earlier, they also noticed a significant decrease in the number of attendees.

 

Some of the exhibitions in Russia are also not doing well, with a pitifully low number of participants. People no longer have the same passion for these exhibitions as before, it feels like they are just going through the motions," lamented this exhibitor.

 

With the abundance of information channels in the e-cigarette market, the diversification of online trading and promotion platforms has made brands no longer rely on offline exhibitions to acquire new customers and partners. With the rise of online channels and social media, brands now have more convenient and precise means of promotion, enabling them to directly reach their target customer groups. As a result, the practicality of exhibitions has decreased.

 

A exhibitor admitted, "In the past, we used to go to trade shows to find agents and distributors, to understand the local market situation, but now the market channels have matured, so participating in exhibitions is no longer as important for us. In the past, trade shows served as a 'distribution center' for the industry, but now companies prefer to do precise advertising through online channels. Instead of participating in large-scale exhibitions, it is more cost-effective to directly connect with target customer groups.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
Former BAT global content lead Andy Parton has left the company and launched Destreza, a London-based AI-native marketing consultancy. Parton previously worked across BAT's New Category brands Vuse, Velo and glo and had also served as Global Brand Lead for Vuse Go. Destreza says it will advise consumer businesses on AI in brand strategy, operating models, capability and agency configuration, using specialist AI agents to support research, strategy and creative development. BAT reported £3.621 billion in New Category revenue in 2025.
Sep.22
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana's Alcohol and Tobacco Commission (ATC) ordered tobacco certificate holders in September to remove certain vaping products marketed under Elf Bar, Lost Mary, MR FOG, iJOY and other brands from inventory under the state's foreign-adversary product law. The agency later listed 257 MR FOG products and 77 Lost Mary product entries as lawful for sale. The Lost Mary revision expressly stated that compliance evidence had been received for 20 additional products. 2Firsts compliance expert Kurt said potential filings could include e-liquid and ingredient-origin records, U.S. nicotine-analog supply-chain documentation and FDA premarket application status.
Regulations
Oct.08
Elf Bar Vape Explosion and Amputation Claim Spurs Coverage Suit, U.S. Insurer MUSIC Seeks Ruling It Owes No Duty to Defend or Indemnify Distributor i5
Elf Bar Vape Explosion and Amputation Claim Spurs Coverage Suit, U.S. Insurer MUSIC Seeks Ruling It Owes No Duty to Defend or Indemnify Distributor i5
Mesa Underwriters Specialty Insurance Company has asked a federal court in Washington to declare that it has no duty to defend or indemnify vape distributor i5 Distribution in a product liability case involving an Elf Bar BC5000. The plaintiff alleges that the disposable vape caught fire and exploded in his pocket, causing severe burns and ultimately requiring an above-the-knee amputation of his left leg. MUSIC is relying on a tobacco, nicotine or nicotine replacement products exclusion and a premises limitation endorsement. The court has not ruled on the coverage dispute.
News
Sep.10
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10